Clinical Trial Update: Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC) [NA]

View source ↗

Summary

The trial investigating hypoxia-guided radiotherapy with cisplatin and etoposide for stage I-III small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Small Cell Lung Cancer (SCLC) | NA | Status: WITHDRAWN